Calvert Research and Oncoceutics announced today a partnership to support the completion of preclinical development for ONC201, Oncoceutics' preclinical stage experimental anti-cancer compound.

Demand for meaningful use (MU) assistance has exploded, increasing competition between third-party consulting firms--most of whom are excelling in MU-related work.

Brett Roveda brings over 25 years of proven business development, management and supply chain experience in asset-intensive industries to role of Vice President of Business Development, Asia-Pacific.

By joining forces with Leimdörfer, Glitnir Property Holding becomes the largest financial advisory on the Nordic property market.